Predialysis NTproBNP predicts magnitude of extracellular volume overload in haemodialysis patients

American Journal of Nephrology

Volumn 40, Issue 3, 2014, Pages 251-257

  Nongnuch, Arkom ^a,c   Panorchan, Kwanpeemai ^b,c   Davenport, Andrew ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b BUMRUNGRAD INTERNATIONAL HOSPITAL   (Thailand)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Bioimpedance; Extracellular fluid volume; Haemodialysis; NT proBNP

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; SARTAN DERIVATIVE; WARFARIN; ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AFRICAN; AFRICAN CARIBBEAN; AGED; ALBUMIN BLOOD LEVEL; ANTICOAGULANT THERAPY; ANTIHYPERTENSIVE THERAPY; ARTERIAL PRESSURE; ARTICLE; ARTIFICIAL KIDNEY; BODY FAT; BODY MASS; BODY WEIGHT; CAUCASIAN; CEREBROVASCULAR DISEASE; CORONARY ARTERY BYPASS SURGERY; CORONARY STENTING; DIABETES MELLITUS; EXTRACELLULAR FLUID; EXTRACELLULAR SPACE; FEMALE; HEART INFARCTION; HEART VALVE REPLACEMENT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERVOLEMIA; IMPEDANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTPATIENT; PERIPHERAL VASCULAR DISEASE; PROTEIN BLOOD LEVEL; SOUTH ASIAN; SYSTOLIC BLOOD PRESSURE; TOTAL BODY WATER; VALVULAR HEART DISEASE; BLOOD; BLOOD PRESSURE; CHEMISTRY; COMPLICATION; CORONARY ARTERY BYPASS GRAFT; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROCEDURES; REGRESSION ANALYSIS; RENAL REPLACEMENT THERAPY; WATER-ELECTROLYTE IMBALANCE;

AGED; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CORONARY ARTERY BYPASS; DIABETES COMPLICATIONS; ELECTRIC IMPEDANCE; EXTRACELLULAR FLUID; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; OUTPATIENTS; PEPTIDE FRAGMENTS; REGRESSION ANALYSIS; RENAL DIALYSIS; WATER-ELECTROLYTE IMBALANCE;

EID: 84908287352     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000368376     Document Type: Article

References (33)

1. Foley RN, Parfrey PS: Cardiovascular disease and mortality in ESRD. J Nephrol 1998; 11: 239-245.
2. Davenport A: How best to improve survival in hemodialysis patients: solute clearance or volume control? Kidney Int 2011; 80: 1018-1020.
3. FHN Trial Group, Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS: In-center haemodialysis six times per week versus three times per week. N Engl J Med 2010; 363: 2287-2300.
4. Paniagua R, Ventura MD, Avila-Diaz M, Hinojosa- Heredia H, Mendez-Duran A, Cueto- Manzano A, Cisneros A, Ramos A, Mandonia- Juseino C, Belio-Caro F, Garcia-Contreras F, Trinidad-Ramos P, Vazquez R, Ilabaca B, Alcantara G, Amato D: NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients. Nephrol Dial Transplant 2009; 25: 551-557.
5. Papakrivopoulou E, Booth J, Pinney J, Davenport A: Comparison of volume status in asymptomatic haemodialysis and peritoneal dialysis outpatients. Nephron Extra 2012; 2: 48-54.
6. Papakrivopoulou E, Lillywhite S, Davenport A: Is N-terminal probrain-type natriuretic peptide a clinically useful biomarker of volume overload in peritoneal dialysis patients? Nephrol Dial Transplant 2012;27: 396-401.
7. Çelik G, Silinou E, Vo-Van C, Jean G, Chazot C: Plasma BNP, a useful marker of fluid overload in hospitalized haemodialysis patients. Hemodial Int 2012; 16: 47-52.
8. Jacobs LH, van der Kerkhof JJ, Mingels AM, Passos VL, Kleijnen VW, Mazairac AH, van der Sande FM, Wodzig WK, Konings VW, Leunissen KM, van Dieijen-Visser MP, Kooman JP: Inflammation overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study. Nephrol Dial Transplant 2009; 25: 243-248.
9. Chazot C, Vo-Van C, Zaoui E, Vanel T, Hurot JM, Lorriaux C, Mayor B, Deleaval P, Jean G: Fluid overload correction and cardiac history influence brain natriuretic peptide evolution in incident haemodialysis patients. Nephrol Dial Transplant 2011; 26: 2630-2634.
10. Agarwal R: B-type natriuretic peptide is not a volume marker among patients on hemodialysis. Nephrol Dial Transplant 2013; 28: 3082-3089.
11. Kumar S, Khosravi M, Massart A, Davenport A: Is there a role for N-terminal probrain-type natriuretic peptide in determining volume status in haemodialysis patients? Nephron Clin Pract 2013; 122: 33-37.
12. Yilmaz Z, Yildirim Y, Aydin FY, Aydin E, Kadiroglu AK, Yilmaz ME, Ulgen MS, Yildiz A: Relationship between fluid status as assessed by bioimpedance analysis and NT-pro BNP, blood pressure and left ventricular mass index in hemodialysis patients. Clin Ter 2014; 165:e52-e58.
13. Davenport A, Willicombe MK: Comparison of fluid status in patients treated by different modalities of peritoneal dialysis using multifrequency bio-impedance. Int J Artif Organs 2009; 32: 779-786.
14. Vernon K, Peasegood J, Riddell A, Davenport A: Dialyzers designed to increase internal filtration do not result in significantly increased platelet activation and thrombin generation. Nephron Clin Pract 2011; 117:c403-c408.
15. Davenport A: Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments. Nephrology (Carlton) 2009; 14: 455-461.
16. Bedogni G, Malavolti M, Severi S, Poli M, Mussi C, Fantuzzi AL, Battistini N: Accuracy of an eight-point tactile-electrode impedance method in the assessment of total body water. Eur J Clin Nutr 2002; 56: 1143-1148.
17. Fürstenberg A, Davenport A: Comparison of multifrequency bioelectrical impedance analysis and dual-energy X-ray absorptiometry assessments in outpatient haemodialysis patients. Am J Kidney Dis 2011; 57: 123-129.
18. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM, Heitmann BL, Kent-Smith L, Melchior JC, Pirlich M, Scharfetter H, Schols AM, Pichard C; Composition of the ESPEN Working Group: Bioelectrical impedance analysis - part I: review of principles and methods. Clin Nutr 2004; 23: 1226-1243.
19. Davenport A: Changes in N-terminal probrain natriuretic peptide correlate with fluid volume changes assessed by bioimpedance in peritoneal dialysis patients. Am J Nephrol 2012; 36: 371-376.
20. Gruson D, Ketelslegers JM, Verschuren F, Thys F: Head-to-head comparison of the prohormone proBNP1-108 with BNP and NtproBNP in patients admitted to emergency department. Clin Biochem 2012; 45: 249-252.
21. Emdin M, Passino C, Prontera C, Fontana M, Poletti R, Gabutti A, Mammini C, Giannoni A, Zyw L, Zucchelli G, Clerico A: Comparison of brain natriuretic peptide (BNP) and amino- terminal ProBNP for early diagnosis of heart failure. Clin Chem 2007; 53: 1289-1297.
22. Lippi G, Fortunato A, Salvagno GL, Montagnana M, Soffiati G, Guidi GC: Influence of sample matrix and storage on BNP measurement on the Bayer Advia Centaur. J Clin Lab Anal 2007; 21: 293-297.
23. Miller WL, Phelps MA, Wood CM, Schellenberger U, Van Le A, Perichon R, Jaffe AS: Comparison of mass spectrometry and clinical assay measurements of circulating fragments of B-type natriuretic peptide in patients with chronic heart failure. Circ Heart Fail 2011; 4: 355-360.
24. Sheen V, Bhalla V, Tulua-Tata A, Bhalla MA, Weiss D, Chiu A, Abdeen O, Mullaney S, Maisel A: The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease. Am Heart J 2007; 153: 244.e1-e5.
25. Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM, Canham RM, Chung AK, Leonard D, Wians FH Jr, de Lemos JA: Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 2005; 112: 2163-2168.
26. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, Vasan RS: Impact of obesity on plasma natriuretic peptide levels. Circulation 2004; 109: 594-600.
27. Fürstenberg A, Davenport A: Assessment of body composition in peritoneal dialysis patients using bioelectrical impedance and dualenergy x-ray absorptiometry. Am J Nephrol 2011; 33: 150-156.
28. Booth J, Pinney J, Davenport A: N-terminal proBNP - marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients? Clin J Am Soc Nephrol 2010; 5: 1036-1040.
29. Chazot C, Jean G, Vo-Van C, Collonge C, Terrat JC, Vanel T, Lorriaux C, Hurot JM, Charra B: The plasma level of brain natriuretic peptide is increased in malnourished haemodialysis patients. Blood Purif 2009; 28: 187-192.
30. Davenport A: Differences in prescribed Kt/V and delivered haemodialysis dose - why obesity makes a difference to survival for haemodialysis patients when using a 'one size fits all' Kt/V target. Nephrol Dial Transplant 2013; 28(suppl 4):iv219-iv223.
31. Spalding EM, Chandna SM, Davenport A, Farrington K: Kt/V underestimates the haemodialysis dose in women and small men. Kidney Int 2008; 74: 348-355.
32. Booth J, Pinney J, Davenport A: Do changes in relative blood volume monitoring correlate to hemodialysis-associated hypotension? Nephron Clin Pract 2011; 117:c179-c183.
33. Kumar S, Khosravi M, Massart A, Potluri M, Davenport A: Changes in upper limb extracellular water content during haemodialysis measured by multi-frequency bioimpedance. Int J Artif Organs 2013; 36: 203-207.